Next 10 |
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...
New distribution partnerships further global expansion plans for the Swoop system, growing the reach of Hyperfine to a total of twelve European countries Hyperfine (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared po...
Portable ultra-low-field MR brain imaging provides affordable and accessible technology that may help physicians monitor ARIA and Alzheimer's disease progression in diverse professional care settings. Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has ...
- Led by Edmond Knopp, MD, VP of Medical Affairs - Welcoming three KOLs to discuss clinical developments in ultra-low-field (ULF) MR imaging Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared por...
2024-05-28 09:22:05 ET More on Hyperfine Hyperfine, Inc. (HYPR) Q1 2024 Earnings Call Transcript Hyperfine, Inc. (HYPR) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Hyperfine Historical earnings data for Hyperfine Financial ...
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared por...
2024-05-24 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you have some spare change jingling in your pocket, it might be worth considering investing that money in penny stocks with good upside potential. The penny stocks on...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming Jefferies Global Hea...
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...